Metastatic phenotype in CWR22 prostate cancer xenograft following castration

BACKGROUND: CWR22 is a human xenograft model of primary prostate cancer (PCa) that is often utilized to study castration recurrent (CR) PCa. CWR22 recapitulates clinical response to androgen deprivation therapy (ADT), in that tumors regress in response to castration, but can recur after a period of...

Descripción completa

Detalles Bibliográficos
Autores principales: Seedhouse, Steven J., Affronti, Hayley C., Karasik, Ellen, Gillard, Bryan M., Azabdaftari, Gissou, Smiraglia, Dominic J., Foster, Barbara A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745026/
https://www.ncbi.nlm.nih.gov/pubmed/26642837
http://dx.doi.org/10.1002/pros.23127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745026/
https://www.ncbi.nlm.nih.gov/pubmed/26642837
http://dx.doi.org/10.1002/pros.23127

Ejemplares similares